Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Modification of Extracorporeal Photopheresis Technology With 5-aminolevulinic Acid in Patients With Cutaneous T-cell Lymphoma or Chronic Graft-versus-host Disease - A Proof-of-concept Study

NCT03109353 is registered in ClinicalTrials.gov with St. Olavs Hospital as lead sponsor.

NCT NCT03109353
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03109353 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Modification of Extracorporeal Photopheresis Technology With 5-aminolevulinic Acid in Patients With Cutaneous T-cell Lymphoma or Chronic Graft-versus-host Disease - A Proof-of-concept Study
Lead sponsor
St. Olavs Hospital
Phase
Phase 1/2
Overall status
Completed
Start date
September 20, 2017
Completion date
December 31, 2022
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic graft versus host disease in skin, cutaneous t-cell lymphoma, unspecified